Our Platform

At Ligature Therapeutics, we have created an FBDD Engine independent of X-ray crystal structure, that allows us to be nimble and efficient, driving the rapid identification and development of a new generation of highly tumor selective, optimized, heterobifunctional TPDs.

Our library of degraders has high potential for potency and optimized physiochemical and pharmacokinetic properties.